May, 2017: BioAegis Chosen to Present at the Cavendish Washington, DC Health Impact Forum

BioAegis Therapeutics, Inc. will present at the Cavendish Global Health Impact Forum in Washington, DC. on May 8, 2017. BioAegis’ technology was chosen as one of the groundbreaking discoveries and innovations at a program billed as “United for Impact: A Multi-sector Collaboration to Transform Health and Lifesciences.” Cavendish brings together participants that “share a passion for well-conceived impact investing, sustainable philanthropy and delivering transformative impact.”